Occult neoplastic cells in the lymph node sinuses and recurrence/metastasis of stage II/Dukes' B colorectal cancer

Oncology Reports

Volumn 25, Issue 1, 2011, Pages 69-73

  Sekido, Yasutomo ^a   Mukai, Masaya ^a   Kishima, Kyoko ^a   Tajima, Takayuki ^a   Hoshikawa, Tatsuhiko ^a   Nakamura, Masato ^b   Nakamura, Naoya ^c   Ogoshi, Kyoji ^d  

^a TOKAI UNIVERSITY HACHIOJI HOSPITAL   (Japan)

^b Departments of Regenerative Medicine   (Japan)

^c Departments of Pathology   (Japan)

^d TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal cancer; Dukes' B; High risk group; Isolated tumor cells; Occult neoplastic cells; Recurrence metastasis; Stage II

Indexed keywords

CYTOKERATIN;

ARTICLE; CANCER CELL; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL SPECIFICITY; CELL STRUCTURE; COLORECTAL CANCER; DUKES' B COLORECTAL CANCER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; METASTASIS; PREDICTIVE VALUE; PRIORITY JOURNAL;

COLORECTAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 78650728212     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00001043     Document Type: Article

References (30)

1. Japanese Society for Cancer of the Colon and Rectum: Multi-Institutional Registry of Large Bowel Cancer in Japan. Cases treated in 1994. Vol. 23. Tokyo, 2002.
2. Makuuchi M and Sugihara K: Knacks and Pitfalls. In: Surgery of the Colon, Rectum and Anus. 2nd edition. Bunkoudou Co., Ltd., Tokyo, 2004.
3. Japanese Society for Cancer of the Colon and Rectum: General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus. 7th edition. Kanehara & Co., Ltd., Tokyo, 2006.
4. Japanese Society for Cancer of the Colon and Rectum: Guidelines for Large Bowel Cancer in Japan. Tokyo, 2009.
5. Mukai M, Sato S, Komatsu N, Nishida T, Shiba K, Ito I, Nakasaki H and Makuuchi H: Correlation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with Dukes' C colorectal cancer. Oncol Rep 10: 1165-1169, 2003.
6. Mukai M, Sato S, Komatsu N, Nishida T, Shiba K, Ito I, Nakasaki H and Makuuchi H: Correlation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with curatively resected Dukes' B colorectal cancer. Oncol Rep 10: 1177-1181, 2003.
7. Mukai M, Sato S, Tajima T, Kimura T, Komatsu N, Ninomiya H, Nakasaki H, Ogoshi K and Makuuchi H: Predicting recurrence and metastasis of stage II/Dukes' B colorectal cancer without lymph node metastasis. Oncol Rep 12: 1127-1130, 2004.
8. Mukai M, Sato S, Tajima T, Kimura T, Komatsu N, Ninomiya H, Nakasaki H, Ogoshi K, Makuuchi H, Predicting recurrence and metastasis of stage III/Dukes' C colorectal cancer with lymph node metastasis. Oncol Rep 12: 1301-1304, 2004.
9. Mukai M, Sato S, Nakasaki H, Saito Y, Nishiumi N, Iwasaki M, Tokuda Y, Ogoshi K, Inoue H and Makuuchi H: Occult neoplastic cells in the lymph node sinuses and recurrence of primary breast, lung, esophageal and gastric cancer. Oncol Rep 11: 81-84, 2004.
10. Mukai M, Sato S, Komatsu N, Kimura T, Ninomiya H, Nakasaki H, Ogoshi K and Makuuchi M: Accuracy of criteria for predicting the recurrence and metastasis of stage I and II gastric cancer without lymph node metastasis. Oncol Rep 12: 59-62, 2004.
11. Mukai M, Sato S, Komatsu N, Kimura T, Ninomiya H, Nakasaki H, Ogoshi K and Makuuchi H: Accuracy of criteria for predicting recurrence and metastasis in stage II and III gastric cancer with lymph node metastasis. Oncol Rep 12: 63-66, 2004.
12. Mukai M, Sato S, Komatsu N, Kimura T, Ninomiya H, Nakasaki H, Ogoshi K and Makuuchi H: Predicting the recurrence/metastasis of stage II and III breast cancer with lymph node metastasis. Oncol Rep 12: 303-306, 2004.
13. Mukai M, Sato S, Komatsu N, Kimura T, Ninomiya H, Nakasaki H, Ogoshi K and Makuuchi H: Predicting the recurrence/metastasis of stage I and II breast cancer without lymph node metastasis. Oncol Rep 12: 745-748, 2004.
14. TNM classification of malignant tumours. 6th edition. John Wiley & Sons, Inc., New York, 2002.
15. Mukai M, Sato S, Nishida T, Komatsu N, Shiba K, Nakasaki H and Makuuchi H: Selection criteria for high risk and low risk groups of recurrence and metastasis in patients with primary colorectal cancer. Oncol Rep 10: 1753-1758, 2003.
16. Mukai M: Occult neoplastic cells and malignant microaggregates in lymph node sinuses: Review and hypothesis. Oncol Rep 14: 173-175, 2005.
17. Nakane PK and Pierce GB: Enzyme-labeled antibodies: preparation and application for localization of antigens. J Histochem Cytochem 14: 929-931, 1966.
18. Nakane PK and Pierce GB: Enzyme-labeled antibody for the light and electron microscopic localization of tissue antigens. J Cell Biol 33: 307-318, 1967.
19. Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D and Martin EW: Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Cancer 73: 563-569, 1994.
20. Nicholson AG, Marks CG and Cook MG: Effect on lymph node status of triple leveling and immunohistochemistry with CAM 5.2 on node negative colorectal carcinomnas. Gut 35: 1447-1448, 1994.
21. Isaka N, Nozue M, Doy M and Fukao K: Prognostic significance of perirectal lymph node micrometastases in Dukes' B rectal carcinoma: an immunohistochemical study by CAM 5.2. Clin Cancer Res 5: 2065-2068, 1999.
22. Prandi M, Lionetto R, Bini A, Francioni G, Accarpio G, Anfossi A, Ballario E, Bacchi G, Bonilauri S, Carobbi A, Cavaliere P, Garcea D, Giuliani L, Morziani E, Mosca F, Mussa A, Pasqualini M, Poddie D, Tonetti F, Zardo L and Rosso R: Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy. Ann Surg 235: 458-463, 2002.
23. Mukai M, Ito I, Mukoyama S, Tajima T, Saito Y, Nakasaki H, Sato S and Makuuchi H: Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: A 17-year retrospective study. Oncol Rep 10: 927-934, 2003.
24. Nelson H, Petrelli N, Carlin A, Couture J, Fleshman J, Guillem J, Miedema B, Ota D and Sargent D: Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 93: 583-596, 2001.
25. Mitomi T, Tsuchiya S, Iijima N, Aso K, Suzuki K, Nishiyama K, Amano T, Takahashi T, Murayama N, Oka H, Oya K, Noto T and Ogawa N: Randomized controlled study on adjuvant immnochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of the Colon and Rectum (Kanagawa). Dis Colon Rectum 35: 123-130, 1992.
26. Mukai M, Tajima T, Nakasaki H, Sato S, Ogoshi K and Makuuchi H: Efficacy of postoperative adjuvant oral immunochemotherapy in patients with Dukes' B colorectal cancer. Ann Cancer Res Ther 11: 201-214, 2003. (Pubitemid 39334896)
27. Mukai M, Tajima T, Nakasaki H, Sato S, Ogoshi K and Makuuchi H: Efficacy of postoperative adjuvant oral immunochemotherapy in patients with Dukes' C colorectal cancer. Ann Cancer Res Ther 11: 215-229, 2003. (Pubitemid 39341153)
28. Ito I, Mukai M, Ninomiya H, Kishima K, Tsuchiya K, Tajima T, Oida Y, Nakamura M and Makuuchi H: Comparison between intravenous and oral postoperative adjuvant immunochemotherapy in patients with stage II colorectal cancer. Oncol Rep 20: 1189-1194, 2008.
29. Ito I, Mukai M, Ninomiya H, Kishima K, Tsuchiya K, Tajima T, Oida Y, Nakamura M and Makuuchi H: Comparison between intravenous and oral postoperative adjuvant immunochemotherapy in patients with stage III colorectal cancer. Oncol Rep 20: 1521-1526, 2008.
30. Mukai M, Ninomiya H, Kishima K, Tsuchiya K, Tajima T, Ito I, Nakamura M and Makuuchi M: Efficacy of 5FU/LV plus CPT-11 as the first-line postoperative adjuvant chemotherapy in patients with stage IIIa colorectal cancer. Oncol Rep 22: 621-629, 2009.